Business Context and Reporting Period
Company: Leucadia National Corporation (Note: The input metadata references "Jefferies Financial Group Inc.", but the filing text explicitly identifies the registrant as Leucadia National Corporation, a diversified holding company.)
Reporting Period: Fiscal year ended December 31, 2006.
Business Overview: Leucadia operates as a diversified holding company with segments in manufacturing (Idaho Timber, Conwed Plastics), domestic real estate, medical product development (Sangart), wineries, and residual banking/lending. The company also holds significant equity interests in associated companies, including gaming (Premier Entertainment Biloxi), oil and gas drilling (Goober), and various investment funds.
Key Financial Metrics
| Metric | 2006 | 2005 |
|---|---|---|
| Total Revenues and Other Income | $862.7 million | $689.9 million |
| Net Income | $189.4 million | $1,636.0 million |
| Income from Continuing Operations | $129.8 million | $1,220.3 million |
| Net Securities Gains | $117.2 million | $208.8 million |
| Total Assets | $5,303.8 million | $5,260.9 million |
| Total Debt (Current + Long-term) | $1,159.5 million | $1,162.4 million |
| Shareholders' Equity | $3,893.3 million | $3,661.9 million |
| Book Value Per Share | $18.00 | $16.95 |
| Cash and Investments | $2,657.0 million | $2,687.8 million |
Material Changes vs. Prior Period
- Net Income Decline: Net income decreased significantly from $1.64 billion in 2005 to $189.4 million in 2006. The 2005 figure was anomalously high due to a $1.135 billion reversal of a deferred tax valuation allowance and a $243.8 million gain on the sale of WilTel (discontinued operations).
- Discontinued Operations: In 2006, the company sold Symphony Healthcare Services (gain of $53.3 million) and ATX Communications (gain of $41.6 million). In 2005, the major gain came from the sale of WilTel ($243.8 million).
- Segment Performance:
- Manufacturing: Idaho Timber revenues increased to $345.7 million (vs. $239.0 million in 2005) but faced margin compression due to oversupply in the lumber market. Conwed Plastics revenues grew 14% to $106.4 million.
- Real Estate: Pre-tax income surged to $44.0 million (from $4.1 million) primarily due to a $48.9 million gain on the sale of land in Washington, D.C.
- Medical: Sangart reported a pre-tax loss of $21.1 million due to R&D costs for its Hemospan product.
- Investments: The company invested $408 million in Fortescue Metals Group (iron ore project) and increased its stake in Goober Drilling. Net securities gains dropped to $117.2 million from $208.8 million.
Guidance, Outlook, Risks, and Unusual Items
- Bankruptcy Proceedings: Premier Entertainment Biloxi (Hard Rock Hotel & Casino) filed for Chapter 11 reorganization in September 2006 to access Hurricane Katrina insurance proceeds. The company deconsolidated Premier and now accounts for it as an associated company. Reopening is expected in July 2007.
- Deferred Tax Assets: The company holds a significant deferred tax asset ($991.9 million) with a valuation allowance of $911.8 million. Realization depends on future taxable income projections.
- Regulatory Risks: Sangart's Hemospan product is in Phase III clinical trials; regulatory approval is uncertain and required for commercialization. Idaho Timber faces risks related to the Softwood Lumber Agreement with Canada.
- Insurance Risks: Premier faces challenges in securing affordable catastrophic insurance coverage following Hurricane Katrina.
- Future Acquisitions: In January 2007, the company agreed to acquire a 75% interest in Telco Group Inc. for $120 million. It is also considering raising approximately $500 million in debt financing.
Investor Verification Checklist
- Deferred Tax Realization: Verify the assumptions used to justify the reversal of the valuation allowance in 2005 and the current $911.8 million allowance balance.
- Premier Bankruptcy Status: Monitor the Chapter 11 proceedings for Premier Entertainment Biloxi, specifically the release of insurance funds and the timeline for reopening the Hard Rock Biloxi.
- Sangart Clinical Trials: Track the results of the Phase III trials for Hemospan, as failure would result in continued losses and no revenue generation.
- Manufacturing Margins: Assess the impact of the Softwood Lumber Agreement and housing market trends on Idaho Timber's gross margins.
- Fortescue Investment: Review the progress of the Pilbara iron ore project and the valuation of the $276.3 million equity stake held by Leucadia.